STERIS Future Growth
Future criteria checks 1/6
STERIS is forecast to grow earnings and revenue by 13.1% and 6% per annum respectively. EPS is expected to grow by 13% per annum. Return on equity is forecast to be 12.2% in 3 years.
Key information
13.1%
Earnings growth rate
13.0%
EPS growth rate
Medical Equipment earnings growth | 17.2% |
Revenue growth rate | 6.0% |
Future return on equity | 12.2% |
Analyst coverage | Good |
Last updated | 15 Oct 2024 |
Recent future growth updates
Recent updates
Is STERIS (NYSE:STE) A Risky Investment?
Oct 01Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Sep 16Earnings Tell The Story For STERIS plc (NYSE:STE)
Sep 13Steris: Q2 Numbers Solidify Buy Thesis
Aug 13STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price
Aug 08When Should You Buy STERIS plc (NYSE:STE)?
Jul 04Is STERIS (NYSE:STE) Using Too Much Debt?
Jun 13Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Is STERIS (NYSE:STE) A Risky Investment?
Jul 19Steris: Deleveraging Key Undercurrent, Valuation A Concern
Jun 12Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 6,207 | 897 | 1,278 | 1,690 | 6 |
3/31/2026 | 5,844 | 790 | 1,104 | 1,354 | 9 |
3/31/2025 | 5,498 | 670 | 798 | 1,103 | 9 |
6/30/2024 | 5,235 | 561 | 594 | 996 | N/A |
3/31/2024 | 5,139 | 551 | 613 | 973 | N/A |
12/31/2023 | 4,885 | 1,024 | 594 | 934 | N/A |
9/30/2023 | 4,705 | 1,007 | 535 | 849 | N/A |
6/30/2023 | 4,563 | 576 | 494 | 806 | N/A |
3/31/2023 | 4,536 | 557 | 395 | 757 | N/A |
12/31/2022 | 4,784 | -28 | 349 | 713 | N/A |
9/30/2022 | 4,777 | -8 | 399 | 752 | N/A |
6/30/2022 | 4,773 | 377 | 472 | 819 | N/A |
3/31/2022 | 4,223 | 285 | 397 | 685 | N/A |
12/31/2021 | 4,248 | 279 | 412 | 701 | N/A |
9/30/2021 | 3,848 | 250 | 400 | 662 | N/A |
6/30/2021 | 3,407 | 286 | 424 | 653 | N/A |
3/31/2021 | 3,108 | 397 | 450 | 690 | N/A |
12/31/2020 | 3,057 | 433 | 476 | 701 | N/A |
9/30/2020 | 3,022 | 424 | 400 | 627 | N/A |
6/30/2020 | 3,003 | 413 | 384 | 615 | N/A |
3/31/2020 | 3,031 | 408 | 376 | 591 | N/A |
12/31/2019 | 2,976 | 393 | 340 | 570 | N/A |
9/30/2019 | 2,898 | 336 | 347 | 573 | N/A |
6/30/2019 | 2,840 | 319 | 336 | 548 | N/A |
3/31/2019 | 2,782 | 304 | 350 | 540 | N/A |
12/31/2018 | 2,730 | 269 | 325 | 490 | N/A |
9/30/2018 | 2,696 | 316 | 314 | 467 | N/A |
6/30/2018 | 2,651 | 303 | 321 | 478 | N/A |
3/31/2018 | 2,620 | 291 | N/A | 458 | N/A |
12/31/2017 | 2,585 | 243 | N/A | 463 | N/A |
9/30/2017 | 2,570 | 144 | N/A | 453 | N/A |
6/30/2017 | 2,582 | 120 | N/A | 424 | N/A |
3/31/2017 | 2,613 | 110 | N/A | 424 | N/A |
12/31/2016 | 2,616 | 142 | N/A | 439 | N/A |
9/30/2016 | 2,588 | 167 | N/A | 364 | N/A |
6/30/2016 | 2,431 | 135 | N/A | 294 | N/A |
3/31/2016 | 2,233 | 111 | N/A | 255 | N/A |
12/31/2015 | 2,042 | 94 | N/A | 185 | N/A |
9/30/2015 | 1,897 | 113 | N/A | 221 | N/A |
6/30/2015 | 1,870 | 135 | N/A | 241 | N/A |
3/31/2015 | 1,842 | 135 | N/A | 246 | N/A |
12/31/2014 | 1,807 | 133 | N/A | 233 | N/A |
9/30/2014 | 1,739 | 123 | N/A | 234 | N/A |
6/30/2014 | 1,660 | 122 | N/A | 223 | N/A |
3/31/2014 | 1,615 | 129 | N/A | 210 | N/A |
12/31/2013 | 1,585 | 132 | N/A | 189 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: STE's forecast earnings growth (13.1% per year) is above the savings rate (2.5%).
Earnings vs Market: STE's earnings (13.1% per year) are forecast to grow slower than the US market (15.2% per year).
High Growth Earnings: STE's earnings are forecast to grow, but not significantly.
Revenue vs Market: STE's revenue (6% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: STE's revenue (6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: STE's Return on Equity is forecast to be low in 3 years time (12.2%).